Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Medifast
MED
$134M
| $18.4M | 0.03% |
144,395
-24,696
| -15% | -$3.13M |
|
852
HF Sinclair
DINO
$16.9B
| $18.4M | 0.03% |
373,782
-150,455
| -29% | -$8.01M |
|
853
Equinor
EQNR
$101B
| $18.4M | 0.03% |
835,736
+447,082
| +115% | +$10.1M |
|
854
uniQure
QURE
$3.29B
| $18.4M | 0.03% |
307,640
-459,458
| -60% | -$20.5M |
|
855
Malibu Boats
MBUU
$579M
| $18.3M | 0.03% |
462,353
+387,569
| +518% | +$16M |
|
|
NUAN
856
DELISTED
Nuance Communications, Inc.
NUAN
| $18.3M | 0.03% |
1,248,374
-1,244,451
| -50% | -$17.3M |
|
857
Microchip Technology
MCHP
$40.3B
| $18.2M | 0.03% |
439,400
+390,940
| +807% | +$16.2M |
|
858
Boyd Gaming
BYD
$5.89B
| $18.2M | 0.03% |
665,787
-1,043,108
| -61% | -$28.5M |
|
859
Acadia Healthcare
ACHC
$2.67B
| $18.2M | 0.03% |
620,870
+591,114
| +1,987% | +$16.7M |
|
860
Aflac
AFL
$59.3B
| $18.2M | 0.03% |
363,158
+79,983
| +28% | +$3.85M |
|
861
Ulta Beauty
ULTA
$23.2B
| $18.2M | 0.03% |
52,065
-223,702
| -81% | -$67.7M |
|
862
Churchill Downs
CHDN
$6.32B
| $18.1M | 0.03% |
+401,694
| New | +$17.9M |
|
|
DLPH
863
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $18.1M | 0.03% |
940,203
-362,174
| -28% | -$6.7M |
|
864
WisdomTree
WT
$3.61B
| $18.1M | 0.03% |
2,561,535
-2,420,850
| -49% | -$16.7M |
|
865
PUT
Mettler-Toledo International
MTD
$28B
| $18.1M | 0.03% |
+25,000
| New | +$16.3M |
|
866
PUT
Baidu
BIDU
$31.3B
| $18M | 0.03% |
109,000
-266,700
| -71% | -$44.6M |
|
867
PagSeguro Digital
PAGS
$2.4B
| $18M | 0.03% |
601,473
+412,722
| +219% | +$10.3M |
|
868
Rigel Pharmaceuticals
RIGL
$843M
| $18M | 0.03% |
698,531
+10,951
| +2% | +$250K |
|
869
Federated Hermes
FHI
$4.83B
| $17.9M | 0.03% |
612,380
-411,994
| -40% | -$11.4M |
|
870
CALL
SLB Ltd
SLB
$80.1B
| $17.9M | 0.03% |
411,600
+11,600
| +3% | +$501K |
|
871
Jazz Pharmaceuticals
JAZZ
$16.5B
| $17.8M | 0.03% |
124,742
-127,664
| -51% | -$16.7M |
|
872
SiriusXM
SIRI
$9.59B
| $17.8M | 0.03% |
314,129
+117,278
| +60% | +$6.99M |
|
873
CALL
BioMarin Pharmaceuticals
BMRN
$12.6B
| $17.8M | 0.03% |
+200,000
| New | +$18.5M |
|
874
Atkore
ATKR
$3.16B
| $17.7M | 0.03% |
824,008
+444,265
| +117% | +$9.93M |
|
|
FPAC.U
875
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $17.7M | 0.03% |
1,700,000
| – | – |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.